Author: Urenus

  • ADONIS VERNALIS

    Common names / Synonyms: Adonis primaveral; Falso heléboro; Ojo de faisán; Adonis vernalis
    Family: Ranunculaceae
    Preparation: Infusion of the tincture of the fresh plant; an extract, Adonidin

    1. IDENTIFICATION
      A plant remedy of the Ranunculaceae family; used in infusion of the tincture of the fresh plant; also prepared as an extract, Adonidin.
    2. CLINICAL (Key clinical indications)
      Albuminuria;
      Affections of the heart;
      Oedema;
      Valvular diseases;
      Cardiac asthma.
    3. CHARACTERISTICS (Keynotes / guiding symptoms)
      Like Convallaria, Adonis is a popular heart remedy in Russia;
      It has not been proved, but indications for its use have been defined by experience;
      Rapid and weak action of the heart;
      Oedemas;
      Scanty urine with albumin and casts;
      Valvular diseases and cardiac asthma;
      There is no record of use in potencies;
      Cash gave great relief to a patient aged 74 years, with water retention and mitral regurgitation, with the dose of one grain of Adonidin every 8 hours, after failure of Arsenicum and Digitalis;
      Urinary secretion increased from half a pint to 2½ pints in 24 hours;
      Respiration improved; sleep returned.
    4. RELATIONSHIPS
      Compare: Digitalis; Convallaria; Strophanthus.
    5. SYMPTOMS
    6. Generalities
      Oedema;
      Rapid and weak cardiac action;
      Improvement in respiration;
      Return of sleep after increase of urinary secretion.
    7. Stomach / Urinary System
      Scanty urine with albumin and casts;
      Urinary secretion markedly increased under Adonidin.
    8. Respiratory Organs
      Cardiac asthma;
      Respiration improved after administration.

    Source Notes: Translated and formatted from user-provided text (Spanish).

  • Therapeutic Report: Lyme Disease

    Lyme arthritis and chronic encephalomyelitis accompanied by paralytic symptoms, occurring mainly in the lower extremities, are typical manifestations of the third stage of Lyme disease. This is caused by an infection with Borrelia burgdorferi, a spirochete harbored by the Ixodes ricinus type of tick.

    Isolation of the infecting organism is costly and often yields inconclusive results. Detection of antibodies against B. burgdorferi via the Indirect Immunofluorescence Assay (IFA) or via the Enzyme Linked Immunosorbent Assay (ELISA) is a reliable method for routine diagnosis of the infection. Specific IgM antibodies may be detected as early as a few days after the onset of the disease, with the highest titre level usually occurring after a period of three to six weeks. A few weeks later, specific IgG antibodies form which eventually reach their highest values in stage three of the disease. A follow-up should, by all means, be performed.

    From the point of view of conventional medicine, the most efficacious treatment of acute Lyme disease accompanied by the development of an erythema chronicum migrans (ECM), includes penicillin and tetracycline. Ceftriaxone (Rocephin®, Roche), a third generation injectable cephalosporin, is an effective treatment for stage three Lyme disease. In all cases, concomitant treatment with antihomotoxic medications is of value to balance unwanted side effects of the antibiotics.


    Encephalomyelitis

    Due to the infectious etiology of chronic encephalomyelitis, oral therapy with Cerebrum compositum, Echinacea compositum, and Engystol, one vial of each three times a week, is indicated. The preparations Coenzyme compositum and Ubichinon compositum should be administered as well, at the above dosage, in order to improve cell metabolism and regeneration of cellular enzymes.


    Lyme arthritis

    Typically, Lyme arthritis presents either as monarthritis or oligoarthritis. The following basic oral therapy has shown good results:

    Rhododendroneel
    10 drops three times daily

    Bryaconeel
    1 tablet three times daily

    Traumeel
    1 tablet three times daily

    Depending on which joint is inflamed, the following preparations may be considered:

    Ferrum-Homaccord
    shoulder

    Rheuma-Heel
    left knee

    Colnadul
    right knee

    Colocynthis-Homaccord
    hip

    Osteoheel
    ankle

    In addition, Echinacea compositum and Traumeel should each be given orally at the rate of one vial, three times weekly. Traumeel ointment is well suited for overnight application using an occlusive dressing with a plastic wrap followed by an Ace bandage.

  • Intravenous Therapy Using Antihomotoxic Preparations

    By Dr. Dagmar Lanninger-Bolling, M.D.

    Intravenous therapy using antihomotoxic ampoules offers a powerful adjunctive approach to support the body’s detoxification systems, especially in patients burdened by chronic illness and toxic overload. This method aligns with the holistic principle in traditional Chinese medicine:
    A distinguished physician prevents illness, a mediocre physician controls present illness, and an undistinguished physician treats illness.

    Therapeutic Rationale

    When the body’s biological systems become overwhelmed or blocked due to environmental toxins, infections, or stress, the natural detoxification pathways may be compromised. This leads to chronic conditions and reduced physiological resilience.

    Antihomotoxic intravenous therapy is especially valuable in:

    • Detoxifying toxic loads
    • Improving cellular function
    • Supporting immune system performance
    • Preventing disease progression

    Patients whose health is deteriorating or who are heavily burdened with toxic substances are ideal candidates for this therapy. By enhancing detoxification and supporting the immune response, intravenous antihomotoxic treatments may slow or even reverse chronic degeneration.

    Personal Experience & Efficacy

    Dr. Lanninger-Bolling reports that over several years, intravenous treatments combining antioxidants with antihomotoxic remedies have been highly effective in clinical practice. This approach has demonstrated success in rapidly reducing toxic burdens and improving patient outcomes in the following conditions:

    • Toxin/noxae load
    • Chronic metabolic disorders
    • Rheumatic and autoimmune diseases
    • Chronic liver issues
    • Chronic fatigue
    • Lowered immune response
    • Digestive system disorders
    • Drop in physical or mental performance

    These treatments are often accompanied by nutritional and probiotic support and guided by individualized protocols.

    Treatment Protocol

    Each patient receives intravenous treatment twice weekly for a total of 10 sessions. Remedies are selected based on clinical indications, including elimination agents, catalysts, compositum preparations, and nosodes.

    Therapeutic protocols are adapted to patient needs. Below are examples:

    1. Amalgam Elimination

    • Base: Ringer’s lactate solution, 250 mL
    • Additions:
      • 7.5 g Vitamin C
      • 1 ampule Selenium
      • 2 ampules Lymphomyosot®
      • 2 ampules Mertrocurium-Injeel®
      • 2 ampules Hepeel®
      • 2 ampules Ubichinon compositum®
      • 2 ampules Solidago compositum®

    2. Basic Detoxification for Metabolic Disorders Caused by Toxins

    • Base: NaCl solution, 250 mL
    • Additions:
      • 7.5 g Vitamin C
      • 1 ampule Selenium
      • 2 ampules Lymphomyosot®
      • 1 ampule Galium-Heel®
      • 1 ampule Hepeel®
      • 1 ampule Solidago compositum®
      • 1 ampule Circulo-Heel®

    3. Metabolic Disorders, Obesity, Rheumatic Disorders

    • Base: Ringer’s lactate solution, 250 mL
    • Additions:
      • 7.5 g Vitamin C
      • 1 ampule Selenium
      • 1 ampule Thyreoidea compositum®
      • 1 ampule Hepar compositum®
      • 1 ampule Solidago compositum®
      • 2 ampules Lymphomyosot®
      • 1 ampule Galium-Heel®
      • 2 ampules Neuralgo-Rheum-Heel®

    Treatment efficacy is not only observed subjectively by patients but also supported by objective laboratory monitoring such as flow cytometry and enzyme function tests.

  • Vertigoheel as Administered in Therapy by Internists

    BIOLOGICAL THERAPY

    JOURNAL OF NATURAL MEDICINE

    BT

    Reprinted from Biological Therapy, Volume X No. 3, June 1992


    Vertigoheel as Administered in Therapy by Internists

    Gabriele Herzberger, M.D.

    A report by Dr. Gabriele Herzberger, M.D., as prepared from an original study carried out by Dr. G. Brückner.

    Approximately one in ten patients who visits an internist suffers from vertigo. For the patients who consult an ENT specialist, the figure is about one in three. As is well known, however, vertigo is a symptom and not a diagnosis. Nevertheless, a very great number of patients with the symptom of vertigo regularly consult a specialist for internal medicine, after having been examined by an ENT specialist who had been unable to determine the cause of the symptom of vertigo.

    For these patients, it is important to prescribe a preparation which is characterized as follows:

    1. Demonstrates good effectiveness with respect to the symptom of vertigo,
    2. causes no undesired side effects,
    3. has been tried and proven effective for many years in private medical practice and in hospital use, does not elicit intolerance from patients, does not undesirably interact with other medication, and does not demonstrate incompatibility with alcohol,
    4. does not have sedative effects.

    The preparation Vertigoheel fulfills all of the above criteria.

    Table 1 provides tabular representation of an analysis of the component symptoms of vertigo, and the area of action of each of the individual constituents of the combination preparation Vertigoheel.

    Table 2 reports on a study involving 118 patients who received concerted therapy for vertigo, and who suffered from this symptom in association with vasomotor vertiginous conditions, cerebrovascular disorders, Commotio cerebri (acute cerebral concussion), post-concussion complaints, Meniere’s Syndrome, and motion-sickness (kinetosis). (See Table 2.)

    At the beginning of their therapy, the majority of patients received initial-dose therapy which was administered in the following doses: one tablet each hour, for a period of 6–8 hours. This massive initial therapy was also carried out for patients for whom initial worsening of symptoms took place during early therapy, and for whom external factors (for example, weather conditions and psychic excitement) aggravated their conditions. This was the case for 16 patients.

    Table 2 reports on the results of therapy with the patients, with results broken down into symptom classifications, age and sex, and extent of success achieved. Assessment of the therapy results achieved with Vertigoheel:

    1. There was no recorded case of unsuccessful therapy, nor was there a case in which it was necessary to change to another medication.
    2. With the exception of patients suffering from kinetosis, a reaction time of several days was necessary — as had been expected — before successful treatment was achieved.

    Table 2: Symptom complexes treated with Vertigoheel tablets, the term of therapy, and results of treatment.

    1. Owing to the chronic nature of the disorders in classifications 1, 2, and 5, successful therapy was possible only through long-term treatment.
    2. No undesired side effects or tachyphylactic phenomena appeared. Vertigoheel has no effect on blood pressure.
    3. Good therapeutic results were achieved even for cases of acute cerebral concussion.
    4. The term of therapy for the group of motion-sickness patients was restricted to the duration of their individual trips. Medication began for this group 1–3 days before their travel began. Logically, the term of their therapy was considerably shorter than the average for the other groups.

    Vertigoheel has proved effective in the therapy of vertigo, especially of central origin. The overall diagnosis comparison reveals that the patients treated with Vertigoheel demonstrated significant improvement in their conditions. This assessment applies equally to patients in all of the following classifications: vasomotor vertigo, acute cerebral concussion, post-concussion complaints, and Ménière’s Syndrome. The effects of Vertigoheel on motion-sickness patients was further analyzed and found to be very good.

    Successful therapeutic effects were therefore able to be achieved for all 118 patients – with the absence of any kind of undesired side effect.

  • An Efficacious Homeopathic Treatment for Acute Migraine Headache

    Dharma Khalsa, M.D.

    Case Report

    D.H. is a 37-year-old female referred for headaches, which she has experienced since childhood. The frequency and severity of her headaches has increased in the last ten years. At the time of her initial presentation to this office, her headaches were incapacitating, occurring daily, and her current treatment was Demerol® and sleep. She had seen many physicians, including a neurologist, and carried the diagnosis of migraine. She had taken numerous medications including NSAIDs, beta blockers, Imitrex®, and Migranal®, without relief. She had also tried a variety of natural remedies including herbal feverfew (tanacetum parthenium) and homeopathic belladonna, also without relief.

    The patient was initially treated with acupuncture, which provided remarkable, virtually pain-free, relief after two treatments. Then, inexplicably, four months after the acupuncture was initiated, she developed a severe headache. The patient then visited her primary care physician who prescribed several medications without success. On the third day, she was seen in this office on an emergency basis.

    D.H. was having a severe unilateral headache centered behind her right temple. She was nauseated, incapacitated, and sat rocking herself back and forth. Her conjunctivae were diffusely injected and she described her condition as “miserable.” She was treated with acupuncture, focusing on the liver which previously had been a successful treatment. After no results she was treated by using a curious meridian which resolved her nausea but her headache worsened. Next she was injected with the medication Traumeel® Injection Solution at a tender spot in the skin above her right temple. Within ten minutes she felt markedly better and left the office very pleased with the treatment. When called six hours later for follow-up, she still felt good.

    This was a very interesting clinical case due to the rapid onset of action of the medication, Traumeel® Injection Solution. In most of the literature, injection therapy with Traumeel® is described as a treatment for chronic musculoskeletal disorders. Follow-up and efficacy is usually measured in weeks, not minutes or hours.

    The patient had queried on discharge whether the medication would ‘wear off’ in four hours, consistent with her prior experience with analgesics of short duration. However, in this case, Traumeel® Injection Solution had both a rapid onset and a long-lasting effect. Neither of these product characteristics are generally associated with allopathic medication, with the possible exception of the ergotamines and serotonin agonists, both of which had failed in this patient.


    The effectiveness of Traumeel® Injection Solution in this case may be due to certain of its ingredients. For example, Traumeel® contains single homeopathic remedies known for their analgesic effect:

    • Belladonna: pain, fullness, especially in forehead; boring headache in the right side of the head²
    • Chamomilla: throbbing headache in one half of the brain³; sensation as if the head were going to burst; semi-lateral headache⁴
    • Hepar sulfuris: boring pain from without to within the right temple⁵
    • Symphytum: headache in forehead⁶

    In a homeopathic proving performed on a slightly different formula of Traumeel® (one which included the remedy Aristolochia clematitis), one of the indications of the complex preparation was mild and severe headaches.⁷

    It is possible that complex preparations possess therapeutic benefits greater than the sum of their constituents.

  • How to Get Glucose Into Cells Naturally

    Prediabetes, Diabetes, Lipids, Muscle Loss and the Path to Reversal

    Most people believe diabetes is caused by eating too much sugar.
    That belief is incomplete.

    The deeper problem begins when glucose cannot enter the cells, even when blood sugar is only mildly raised. This silent malfunction starts years before diabetes is diagnosed — during prediabetes — and it is where the real damage begins.


    The Critical Role of Lipids (Fat) in Insulin Resistance

    Glucose enters cells through insulin receptors embedded in the cell membrane, which is largely made of lipids (fats).

    When excess fat accumulates particularly visceral fat and liver fat the cell membrane becomes inflamed and rigid.

    This leads to:

    • Impaired insulin receptor signalling
    • Reduced movement of glucose transporters (GLUT-4)
    • Glucose remaining in the bloodstream

    At the same time, fat-derived toxins such as ceramides and diacylglycerols actively block insulin action inside the cell.

    As a result:

    • Blood glucose rises
    • Cells remain energy-starved

    This is insulin resistance, the core defect behind type 2 diabetes.


    Prediabetes: The Most Dangerous Stage

    Prediabetes is often dismissed because:

    • Fasting glucose may be “borderline”
    • HbA1c may not appear alarming
    • Symptoms are vague or absent

    Yet internally:

    • Glucose entry into muscle is already impaired
    • Visceral fat is increasing
    • Muscle mass begins to decline
    • Lipid toxicity is accelerating

    Prediabetes is not a warning it is active metabolic disease in progress.


    Why the Brain Drives Carbohydrate Cravings

    The brain monitors cellular energy availability, not just blood sugar.

    When glucose cannot enter cells:

    • The brain interprets this as starvation
    • Hunger hormones increase
    • Cravings focus on fast carbohydrates

    This explains why insulin-resistant individuals often:

    • Feel hungry soon after meals
    • Crave sugar in the evening
    • Feel fatigued yet restless

    Eating more sugar does not solve the problem — it intensifies it.


    Why Fat Accumulates in the Abdomen

    When muscle cells resist glucose uptake, insulin diverts glucose into fat storage.

    In men:

    • Glucose preferentially converts into visceral fat
    • Liver fat rises early
    • Cardiometabolic risk increases rapidly

    In women:

    • Pre-menopause: more subcutaneous fat storage
    • Post-menopause or under chronic stress: visceral fat dominance

    Visceral fat is biologically active. It releases inflammatory signals that worsen insulin resistance, creating a self-reinforcing cycle.


    Muscle Loss: The Overlooked Complication

    Skeletal muscle is the body’s primary site for glucose disposal.

    With insulin resistance:

    • Glucose uptake by muscle declines
    • Insulin’s muscle-building signal weakens
    • Muscle protein breakdown increases

    The result is sarcopenic diabetes:

    • Less muscle
    • Lower metabolism
    • Worsening blood sugar control

    Loss of muscle accelerates diabetes progression.


    After Diabetes Develops

    As insulin resistance persists:

    • Insulin production initially increases, then declines
    • Lipid abnormalities worsen
    • Microvascular damage begins (nerves, eyes, kidneys)

    Yet an important fact remains:

    Type 2 diabetes is often reversible — particularly in its early stages.


    What Reversal Actually Means

    Reversal is not about suppressing sugar numbers.

    It is about restoring cellular glucose entry.

    This requires:

    1. Reduction of visceral and liver fat
    2. Rebuilding muscle mass
    3. Improving insulin receptor sensitivity

    When these occur, glucose control improves naturally.


    Role of Supplements (Supportive, Not Curative)

    Supplements may support metabolic recovery when combined with lifestyle change.

    Commonly studied nutrients include:

    • Magnesium (insulin signalling)
    • Vitamin D (receptor sensitivity)
    • Omega-3 fatty acids (lipid inflammation)
    • Alpha-lipoic acid (glucose utilisation, nerve support)
    • Chromium (modest insulin action support)
    • Vitamin B12 (especially with metformin use)

    Supplements cannot replace physical activity or dietary correction.


    Exercise: The Most Reliable Intervention

    Physical activity enables glucose uptake independent of insulin.

    Effective strategies include:

    • Daily walking (especially after meals)
    • Resistance training 2–3 times per week
    • Frequent low-intensity movement throughout the day

    Exercise:

    • Clears toxic intracellular fat
    • Restores insulin signalling
    • Rebuilds muscle
    • Reduces cravings naturally

    Conclusion

    Diabetes is not simply excess sugar in the blood.
    It is a condition of lipid-blocked receptors, muscle loss, and cellular starvation.

    Prediabetes is the stage where reversal is easiest.
    Delay allows damage to compound.

    The body is designed to recover when the correct signals are restored.

  • The Integration of Complementary Therapies into a Conventional Primary Care Practice

    William Bergman, M.D.

    This presentation was delivered by Dr. Bergman on June 30th, 1997 in San Antonio, TX.

    This morning I will be talking about the integration of what is referred to as complementary, or alternative, medicine with conventional medicine. I think that this is the emerging paradigm of healthcare as we are going to be seeing it in the next century. There is no longer a separation between conventional medicine and what is now referred to as alternative, but rather an integration in cases where we can see that by using a combined approach we can bring greater benefit to the patient.

    An important study published in the New England Journal of Medicine in 1993, by Eisenberg and associates, looked at the prevalence and the use of complementary therapies, such as acupuncture, chiropractic, and other forms of non-conventional therapy. One in three respondents reported using at least one unconventional therapy in the previous year; and a third of these had seen providers for the alternative treatment, with an average of 19 visits to such providers. A majority was using unconventional therapy for chronic problems rather than for critical situations where, of course, conventional treatment would be required. Extrapolation of the results of this study to the United States population would amount to an estimated 425 million visits to providers of unconventional therapy, which is a number that would exceed the total number of visits to all U.S. primary care physicians. The expenditures related to this use of non-conventional therapy amounted to $13.7 billion, three quarters of which was being paid for out of pocket. In other words, people were truly interested in accessing this alternative treatment even though it is not necessarily reimbursable. The conclusions of this study are that the frequency of unconventional treatment in the United States is far higher than previously reported and that medical doctors should ask about their patients’ use of unconventional therapy whenever they obtain a medical history.

    I was looking at an article in Family Practice News about three weeks ago where they were saying that physicians in primary, family practice who were incorporating at least a few forms of alternative treatment were at a clear advantage with regard to what patients were looking for. You can see this kind of trend growing, as the public becomes more and more aware of the fact that there are alternatives to conventional medicines, which sometimes can create side effects or adverse reactions. Earlier this year a front-page story appeared on the FDA’s plans to remove Seldane® from the market. That is just one example of the kind of thing that more and more of the population is becoming aware of. In the publication Archives of Internal Medicine in 1995 they looked at drug-related morbidity and mortality, which was estimated in one year to cost over $76 billion in the ambulatory setting in the United States. They felt, of course, that this represented a serious medical problem that urgently required expert evaluation and assessment.

    An important landmark in the development of consciousness concerning complementary treatment occurred in 1992 when, for the first time, the federal government, through the National Institutes of Health, organized an Office of Alternative Medicine which specifically is to use public funds to facilitate the evaluation of alternative medical treatment modalities, to investigate and evaluate the critical efficacy of alternative treatments, to establish an information clearing house, and to support research. Also, the American Medical Association for the first time a few years ago passed a resolution in which the House of Delegates adopted a position encouraging AMA members as individuals and as groups to become better informed regarding alternative, complementary medicine and to participate in appropriate studies about it. They went on to say further that the AMA considered it important to initiate at the state level similar kinds of research and discussions as were being done on a national level in Washington, DC.

    We also see a trend in conventional medical education recognizing the importance of educating the medical students in alternative treatment. There are now probably more than 50 schools, including Mt. Sinai in New York City, Columbia University, Harvard, John’s Hopkins, Tufts, and Yale – some of our finest schools are now adding courses of alternative and complementary medicine to the curriculum of the medical schools.

    Now what are some of the major modalities that are being researched at the National Institutes of Health’s Office of Alternative Medicine? They have broken them down basically into seven categories: Mind/body interventions, which include such things as biofeedback, relaxation therapies, meditation, hypnosis, and imagery. Bioelectromagnetic therapies, which would, for example, include the use of electrical currents or magnetic fields to provide the healing of non-uniting bone fractures, or transcutaneous electrical nerve stimulation for pain management. The NIH is also looking at alternative systems of medical practice from various cultures, such as the Ayurvedic system from India, classical Chinese botanical medicine, acupuncture, and the European system of homeopathy. The Office of Alternative Medicine is also looking at manual healing methods, including osteopathic, chiropractic, and a variety of hands-on healing techniques. They are also looking at botanical or herbal medicines and at the role of diet and nutrition in clinical practice. The seventh category involves a kind of miscellaneous research of various pharmacological and biological treatments including shark cartilage supplements for arthritis, chelation therapy for the treatment of cancer, and intravenous nosode therapy for atherosclerosis and coronary artery disease. These are the kinds of things that are being looked at, with public money, at the NIH through the Office of Alternative Medicine.

    What I would like to do for this presentation is especially draw upon my own experience in an integrated medical practice in Manhattan where for seventeen years I have been working primarily with homeopathic medicine, clinical nutrition, and stress management. One of the most important concepts in this alternative complementary paradigm is the recognition that the body has its own capacity for self-healing. We see this, of course, in wound healing, but much more globally we can recognize that this system has inherent capacity for restoring health and balance. That is, if we can help balance the system, looking at it as a whole, we can facilitate the natural tendency for the self-restorative capability inherent within the body. From this point of view it is clear that symptoms — and I am always educating my patients to recognize that the word symptom is a Greek word that means signal — that basically, symptoms are nature’s way of expressing imbalance. If we ignore those symptoms, we face the risk of more serious conditions that will develop later. I am always trying to educate that symptoms are nature’s way through your own body of explaining that something has got to change, that new directions need to be taken, and that if we respond to nature’s warnings, we often can reduce the risk of more serious problems later on. Of course we publicize this viewpoint in our reception area to our patients that we are not looking at alternative medicine as a panacea. The physician in the initial intake, of course, needs to explain that homeopathy isn’t for everything. We are always trying to help the patients understand that we’re looking at an integrated paradigm where we can combine alternative treatments with conventional treatments to help bring them greater benefit.

    Homeopathic medicine is a European system, which began about 200 years ago through the work of a German physician, Samuel Hahnemann. At the very start, the controversy about homeopathic medicine is that we are dealing with very, very small doses of highly diluted, natural substances that beginning 200 years ago were noted in clinical practice to catalyze a biological response, that is, to bring about a curative or beneficial result in a sick individual. But right from the beginning the controversy was: How could anything so dilute still be causing any kind of biological effect? Well, that controversy has remained even to today. For example, look at this particular study published in the prestigious, peer-reviewed journal, Lancet, where Dr. Reilly and associates were asking the question: Is homeopathy a placebo response? In a randomized, double-blind, placebo-controlled trial, the study model compared the effects of a homeopathic, highly diluted preparation of mixed pollen grasses with a placebo control in 144 patients with active hay fever. We can see the symptomatic improvement in the patients that received the homeopathic preparations. That is, symptomatic improvement in their hay fever symptoms versus the controls that did not. This again was a peer-reviewed journal, a double-blind, controlled study. In addition, the British Medical Journal in 1991 undertook a meta-analysis which looked at 107 controlled trials of homeopathy in 96 published reports. Their aim was to look for the efficacy of homeopathy in humans. They drew upon all of these published reports and their conclusion was that the evidence presented would probably be sufficient for establishing homeopathy as a regular treatment for certain indications. Of course, we need better research and we are hoping that now that NIH’s Office of Alternative Medicine is involved in examining the clinical efficacy of alternative medicine, that we will be seeing better research confirming the clinical effects of homeopathic treatment.

    One of the most important medicines that I use in my practice, that perhaps some of you have had experience with already, is the homeopathic combination preparation called Traumeel®. What I would like to do particularly through this presentation is give you some ideas on certain practical tools that you can bring back to your practice and make available to your patients. I would also like to be able to go through a few of the homeopathic preparations that I use extensively that are very easy to incorporate immediately for the benefit of your patients. Traumeel® is a natural, anti-inflammatory agent that can be used any time there is an injury of any kind. Post-operatively, for swollen soft tissues, and any kind of inflammatory process, you can consider the use of this homeopathic combination medicine. You will be able to see the results without putting patients at any risk of side effects. There have been no reported side effects with the use of Traumeel®, which has been used extensively. For example, in Germany they looked at 3,000 physicians who were using Traumeel® in over three and a half million cases. It was a cross section of physicians from many different specialties — of whom 57.2% were in general practice, and then there were internists, orthopedists, pediatricians, and other types of physicians. They found that in over 99.99% of the cases, patients were receiving benefit without any problems of side effects. In a few cases the side effects might have been classified as allergic reactions to some kind of component within the formulation. But you can see after 3,600,000 cases it was a very good result.

    Any time that there is acute or chronic inflammation in the upper respiratory area, such as sinusitis, viral, bacterial, or allergic rhinitis, use Euphorbium compositum. It comes in both an oral drop and a nasal spray. One of the clinical benefits of this particular medicine is that people can use it in cases of chronic problems without having habituation effects or rebound effects on discontinuation of the medicine. In one particular study they looked at nasal airflow resistance. They were measuring nasal airflow resistance after the application of Euphorbiim Nasal Spray, two puffs in each nostril, and you can see again the improvement in the flow through the nostrils. Two other medicines that I use generally in combination are Gripp-Heel® and Engystol®. Gripp-Heel® is a wonderful combination homeopathic medicine to use in cases of the flu, or for any kind of upper respiratory infection, or any kind of infection. It is safe and effective and you don’t have to worry about side effects. Gripp-Heel® can be used not only for viral illnesses but any time you want to mobilize the immunological response. In one study they looked at the immune stimulating effects of Engystol®, Gripp-Heel® and then a combination of both medicines together at various dilution factors; what they were looking at was the increase in phagocyte activities of human granulocytes in vitro. A related study looked at an in vivo study in mice. This particular slide refers to an in vitro study of human granulocytes. What we are seeing is an increased reactivity of the phagocytes.

    Another very important homeopathic combination that I use extensively in my practice is Lymphomyosot®. Lymphomyosot® is a homeopathic preparation that will increase the capacity of the lymphatic system to drain. Anytime there is a congestive disturbance, tonsillitis, or enlarged tonsils, in children or adults, — and we see many, many children with swollen lymph nodes, recurrent ear infections, congestive disorders in the upper respiratory area, and bronchitis — we use Lymphomyosot® in addition to other homeopathics. One of the most effective uses of this particular medicine is what is referred to as non-specific infections where there is a general susceptibility to infection. In my practice, which is a general family practice, we see the full range of primary care problems, but the number one problem that brings new patients to our office is recurrent ear infections in children. It is not uncommon for us to see kids who have been on 10 – 15 – 20 courses of antibiotics. Of course, the parents’ concern is that the child seems to be so susceptible to any kind of upper respiratory problem. They get a cold, and then the upper respiratory congestion will result in an ear infection. They’ll go on an antibiotic. Sometimes they need a second course of antibiotics. Other times they have to be on prophylactic antibiotics. This is the number one kind of story that we’ll hear in our practice. I can tell you that Lymphomyosot® just does a beautiful job. I’ll treat the children acutely with the appropriate medicines and dietary counseling and, of course, use Lymphomyosot® to bring about a response in the active phase. Then I will tell the parents to continue the use of Lymphomyosot® after the acute illness has resolved. Many times I’ll keep the kids on Lymphomyosot® possibly a month or two, sometimes longer, and almost invariably, certainly not in every case, but almost invariably, the parents will be reporting back that the child is no longer getting sick nearly as frequently, that the bouts of upper respiratory problems are of shorter duration, of less intensity, that they are bouncing back much more quickly. The main thing is that they are just not getting sick as frequently.

    Here we see a study where they used Lymphomyosot® in Europe for (or against) any kind of lymphatic or lymph node enlargements. They found a successful therapeutic response rate of more than 89% of the patients with hyperplasia of the tonsils and other good results using Lymphomyosot®. In this particular study they were looking at the therapy of tonsillitis and prophylaxis against each recurrence. They looked at the response of the physicians and the parents the first winter and then the second winter as a result of using Lymphomyosot®. They were treating kids who tended to get recurrent tonsillitis. They were asking the physicians and the parents what kind of result was happening the first winter and the second. You can see from the bar graphs both physicians and parents were reporting very good therapeutic response using this medicine both in the first winter and successive winters as well.

    One of the things that I try to educate my patients, the parents with children and the parents in general, is this more global concept that nature has the ability to heal. What we want to do is create a context for healing. We want to give specific medicines and specific treatments but we also want to mobilize the natural tendency of the body to repair and heal itself. One of the most important concepts that I share with patients is the fact that there are toxins we have brought in through the environment, particularly through the foods, the air, and the water; toxins which put pressure on the system and which make it more difficult for our natural recuperative abilities to be mobilized.

    The concept here is to help to detoxify the body. It’s a global effect, a systemic effect, where you are not talking about just a specific organ or specific organ network or a specific critical condition, but more systematically about the impact of environmental toxins on the whole system. I share with patients the concept of metabolic clearing. I talk to them about the importance of helping and supporting the liver, which is the main organ for cleansing and detoxification of the body. I remind and educate the patients so they can understand that the impact of the environment is very real.

    There are increasingly more and more sophisticated ways of supporting the body’s effort to cleanse and detoxify toxins. But at the very least, I am always recommending to patients that they emphasize a diet which moves in the direction of whole, natural foods, trying to get them away from a lot of meat, and processed foods. This is an important concept, from my point of view, to continually remind patients that if they are on a sound diet, it makes everything much easier. It takes a lot of stress off of their system and whatever the illness, if they can make changes in their diet and in their lifestyle, this takes pressure off the system. Their system can more easily repair and recuperate.

    The other thing I talk to patients about is the importance of a modest amount of food supplementation, irrespective of the particular disease entity that we might be dealing with clinically. This leads to the importance of the gastrointestinal flora. Information that we are beginning to get now researches the immunological importance of a viable gastrointestinal flora. The fact is that using a lot of antibiotics can disturb the gastrointestinal bacteria, so we want to retrofit the flora using what is referred to as a probiotic supplement, an acidophilus or bifidus-type product which is available these days in any kind of health food store. Some doctors like to carry these products in their office. Other doctors just send their patients to a nearby health food store. Keep probiotics in mind and, of course, speaking to your patients about the importance of antioxidants.

    All these are just some of the tools. Of course, we are always talking to patients about the importance of getting out into the fresh air and exercising. Also, I make a point in every case of helping the patient understand how stress, psychological stress, has a bearing on their capacity to heal. Again, even if it isn’t necessarily a stress-related disorder. Many times if I ask patients: Why do you think you’re sick? They’ll usually say to me the first thing: I don’t know, I have just been so stressed out. I hear that continually from patients. Patients coming to us will often have this kind of mindset. Still, I think that more and more patients now understand that there is a relationship between what’s happening with them psychologically and what’s happening with them physiologically. We talk about the mind/body connection, which is being talked about a lot, psychoneural immunology. I wouldn’t say it’s a household word, but it’s definite that people can understand that there’s a connection between the mind and body and health and illness. From my point of view, the most practical meaning of the mind/body connection is patient education. We want to affect their thinking and their belief systems. On that basis we will be able to help them with their health. And so in our office we have many different handouts, articles, sometimes entire magazines. We make it popular, we make it available.

    In short, we want to provide some real strategies for dealing with these cutting edge healthcare concepts.

  • ARTHRITIS and RHEUMATISM

    Traumeel is a well-known non-steroidal, anti-inflammatory that quickly reduces swelling by acting on the circulatory system and on the connective tissue matrix. It is a staple in any protocol for rheumatism or arthritis. The tablets can be taken at a rate of 3–5 times daily for maintenance of a chronic arthritic or rheumatic condition. It is best to use the ampoules during the acute phase and if possible, use them as injectables; either i.v. or s.c. at the rate of 2–4 ampoules a week for 2–4 weeks depending on the severity of the condition. A 2-week protocol is the minimum.

    Zeel acts systemically, specifically on the connective tissue matrix, the lymphatic system, and on enzymes. It can be useful in cases of rheumatism and of arthritis with the following typical protocol: 1 ampoule 2×/week i.v., s.c., or orally for 5 weeks + 1 Traumeel ampoule 2×/week i.v., s.c., or orally for 8 weeks. These products can be given or taken together. Injections may be replaced by tablets at the following rate: Zeel: 1 tablet 3×/day for 5 weeks + Traumeel tablet 3×/day for 8 weeks.

    For acute « spot » swellings and painful aggravation, apply Traumeel or Zeel ointment. Applying both Traumeel and Zeel ointment on an alternating basis can be beneficial in relieving acute phases of the disease and its associated pain. Alternate by using Traumeel ointment in the morning and Zeel in the afternoon or evening. Three daily applications to the affected area are ideal during the acute phase: Traumeel in the morning, Zeel in the afternoon, and Traumeel before bedtime.

    Discus compositum acts at the structural level right on bone and enzyme systems. It is usually used after the acute phase, i.e., after the initial inflammatory response, and in conjunction with Zeel, Traumeel, or both. A typical protocol for arthritic conditions would be: Discus compositum 1 ampoule 2 days in a row orally, then 1–2×/week for 2–3 weeks. Give in conjunction with maintenance doses of Traumeel. Zeel can be added during the second week at the rate of 1 ampoule every other day. Or use the tablets at a rate of 1 tablet 3×/day for 10 days.


    GENERAL PROTOCOL FOR ARTHRITIS DURING THE ACUTE PHASE:
    1 Traumeel ampoule 3×/week i.v., s.c., or orally for 5 weeks


    GENERAL PROTOCOL FOR RHEUMATISM DURING THE ACUTE PHASE:
    1 Zeel ampoule 3×/week for 2 weeks


    MAINTENANCE PROTOCOL FOR ARTHRITIS/RHEUMATISM
    1 Traumeel tablet 2–3×/day indefinitely (for anti-inflammatory effect).
    1 Zeel tablet 2×/day for 1 month and then review.

  • Antihomotoxic mesotherapy of soft-tissue sports injuries

    Ignacio Ordiz, Jorge Egocheaga, Miguel del Valle
    English translation from original German publication: Biologische Medizin 2002;31(4):64–67

    ABSTRACT

    This retrospective study investigated the efficacy and tolerability of antihomotoxic mesotherapy (intradermal microinjection therapy) for sports injuries. 158 athletes with a variety of injuries were treated with a combination of Traumeel and Zeel, with the addition of Spascupreel in some cases. In 81% of the cases, the injury either healed completely or improved significantly. In most cases of complete healing, a maximum of four treatments were required. No adverse effects were observed.

    ¹ The authors received the 2001 Hans-Heinrich Reckeweg Prize for this paper.


    Fundamentals of mesotherapy

    Mesotherapy, or intradermal injection of mixtures of medications, is used especially for acute and chronic pain. More than forty years of experience indicate that this procedure increases the positive effects of the medication while adverse effects are significantly reduced due to less frequent administration. Poorly administered mesotherapy, however, can cause iatrogenic damage such as pain, inflammation or swelling.

    Multiple studies and clinical experience suggest that effective mesotherapy depends on two basic factors:

    1. Depth of injection: Dependent on the depth of the injection, the medication in any case infiltrates connective tissue matrix, which then stores and distributes the medication. Medication injected by this method not only reaches subcutaneous free nerve endings (cutivisceral reflex arcs), but also influences acupuncture points and meridians.
    2. Multiple microdoses: Any medication becomes effective only when it is taken up by a receptor. Presumably, dividing the dose among several injection sites stimulates a larger number of receptors, thus achieving a greater therapeutic effect than if the entire dose were injected in one place.

    Mesotherapy and sports medicine

    Mesotherapy meets all the prerequisites for effective therapy of sports injuries, especially in competitive athletes:

    1. Rapid healing permits earlier resumption of athletic activity.
    2. Complete healing without sequelae allows training to be resumed with minimal setbacks.
    3. Adverse effects are minimized.

    Mesotherapy is especially indicated for:

    • isolated tendopathies
    • mild to moderate sprains
    • muscle strains
    • minor contusions
    • moderate contractures of joint capsules, tendons or muscles
    • some types of mechanical damage to peripheral nerves and tendons
    • plurifocal joint damage
    • degenerative mechanical damage to the spinal cord
    • postoperative symptoms, including pain

    It is also suitable as an adjuvant measure in functional rehabilitation and physiotherapy.

    It is not suited for treating fractures, severe sprains, certain neurological injuries, meniscus disorders or injuries that require surgical intervention. Whether or not to administer mesotherapy must be decided on a case-by-case basis in injuries such as avulsed tendons or severe strains or in certain underlying illnesses that are discovered or exacerbated because of the injury (e.g. infections, tumors). Mesotherapy should not be implemented if the skin covering the injured area is infected or if large hematomas are present.

    Mesotherapy is also not suitable for patients who cannot overcome their fear of injections.

  • Thyreoi­dea compositum

    DROPS · INJECTION SOLUTION

    Compositions:
    Drops: 100 g containing: Glandula thyreoidea suis D8, Thymus suis D10, Splen suis D10, Medulla ossis suis D10, Funiculus umbilicalis suis D10, Hepar suis D10, Galium aparine D4, Sedum acre D6, Sempervivum tectorum ssp. tectorum D6, Conium maculatum D4, Euspongia officinalis D8, Acidum sarcolacticum D4, Fucus vesiculosus D6, Calcium fluoratum D10, Colchicum autumnale D4, Viscum album D3, Cortisonum aceticum D28, Pulsatilla pratensis D8, Sulfur D10, Natrium diethyl­oxalaceticum D8, Acidum fumaricum D8, Acidum DL-malicum D8, Acidum alpha -ketoglutaricum D8, Adenosinum triphosphoricum D8 4 g each. Contains 35 vol.-% alcohol.
    Injection solution: 2.2 ml containing: Glandula thyreoidea suis D8, Thymus suis D10, Splen suis D10, Medulla ossis suis D10, Funiculus umbilicalis suis D10, Hepar suis D10, Galium aparine D4, Sedum acre D6, Sempervivum tectorum ssp. tectorum D6, Conium maculatum D4, Euspongia officinalis D8, Acidum sarcolacticum D3, Fucus vesiculosus D6, Calcium fluoratum D10, Colchicum autumnale D4, Viscum album D3, Cortisonum aceticum D28, Pulsatilla pratensis D8, Sulfur D10, Natrium diethyl­oxalaceticum D8, Acidum fumaricum D8, Acidum DL-malicum D8, Acidum alpha-ketoglutaricum D8, Adenosinum triphosphoricum D8 22 mg each.

    Indications:
    Stimulation of the defense system in connective tissue, thyroid and other glandular dysfunctions.

    Contraindications:
    Pregnancy and lactation. Viscum album containing products should not be used in persons with known allergies to mistletoe, in cases of chronic granulomatous and autoimmune diseases, and in cases of hyperthyroidism with an unbalanced metabolic condition. In acute inflammatory and highly feverish conditions, discontinue treatment until the inflammation and fever have disappeared.

    Side effects:
    A minor increase of body temperature, localized inflammatory reactions around the site where the subcutaneous injection was given as well as transient insignificant swellings of regional lymph nodes are harmless. Occasionally, veins may respond, presenting inflammatory irritative symptoms. A temporary interruption of the therapy will be necessary in that case. In the presence of an intolerance to mistletoe, there are rare cases where local or general allergic reactions or reactions similar to allergies, such as a generalized itchiness, urticaria, rash, swelling in the face (Quincke’s edema), shivering fits, dyspnea, sudden fall in blood pressure, shock, may occur; such reactions will require a discontinuation of the drug and an immediate medical treatment. In rare cases, an activation of inflammations may occur (eg, chronic sinusitis, apical granulomas).

    Interactions with other medication:
    None known.

    Dosage:
    Drops: Standard dosage: Adults (and children 12 yrs. and older): 10 drops 3x daily. Acute or initial dosage: Adults (and children 12 yrs. and older): 10 drops every ½ to 1 hr., up to 12x daily, and then continue with standard dosage.
    Injection solution: Standard dosage: Adults (and children 12 yrs. and older): 1 ampoule 1 to 3x weekly. Thyreoidea compositum injection solution may be administered by the s.c., i.d., i.m. or i.v. route.
    Acute or initial dosage: Adults (and children 12 yrs. and older): 1 ampoule daily, and then continue with standard dosage.

    Package sizes:
    Drops: Drop bottles containing 30 and 100 ml. (65812)
    Injection solution: Packs containing 10 and 100 ampoules of 2.2 ml each. (65908)

    Pharmacological notes
    Glandula thyreoidea suis: goiter, obesity-related cancerous conditions, and myxedema.¹˒²˒³
    Thymus suis: growth hormone disorders,¹˒³ cancerous conditions,¹˒² immune disorders, and lymphatic disorders.³
    Splen suis: anemia, leukemia, agranulocytosis,¹˒³ and immune deficiency.¹˒²
    Medulla ossis suis: anemic conditions, leukemia, agranulocytosis, coxitis, osteomalacia, chronic osteomyelitis, exostosis, arthritis deformans, and Morbus Sudeck.¹˒³
    Funiculus umbilicalis suis: chronic pathological features that involve the connective tissue.¹˒³
    Hepar suis: liver damage in general.¹˒³
    Galium aparine: cancer.⁴˒¹⁰
    Sedum acre: cancer.⁴˒⁹˒¹¹
    Sempervivum tectorum ssp. tectorum: cancer.⁴˒⁶˒¹²
    Conium maculatum: cancerous tendency,¹⁰˒¹³˒¹⁷ affected lymph glands,⁴˒⁵˒¹³˒¹⁸˒²⁷ and exhaustion.⁷˒⁸˒¹⁸˒²²˒²⁸˒³⁴
    Euspongia officinalis: lymphatic disorders,⁵˒⁸˒⁹˒¹¹˒¹⁶˒¹⁷˒²⁰˒³⁰˒³⁵˒³⁷ and hypertrophied thyroid glands.⁵˒⁷˒¹⁴˒¹⁸˒²¹˒²²˒²⁶˒²⁸˒³⁵˒³⁶˒³⁸˒⁴⁰
    Acidum sarcolacticum: painful cervical glands⁹˒¹⁰ and precancerous conditions.⁹˒¹¹˒⁴¹
    Fucus vesiculosus: thyroidal complaints and goiter.⁴˒⁸˒¹¹˒³⁹
    Calcium fluoratum: goiter,⁴˒⁷˒¹²˒²⁶˒³⁰˒⁴⁰ thyroiditis,⁴¹ and cancerous affections.⁸˒⁹˒²⁴
    Colchicum autumnale: goiter⁸ and gouty diathesis.⁴˒⁵˒⁹˒¹⁴˒¹⁸˒²⁰˒²¹˒²³˒²⁴˒²⁶˒²⁸˒³⁰˒³⁴˒³⁶˒³⁸˒⁴¹˒⁴²
    Viscum album: cancer.⁸˒⁹˒⁴¹
    Cortisonum aceticum: thyroidal complaints,⁹ goiter,¹¹˒⁴¹ damaged connective tissue,¹ and adrenal damage.¹˒³
    Pulsatilla pratensis: goiter,⁸ lymphatic disorders,⁸˒⁹˒²⁰˒²⁴˒³⁰˒³¹˒³⁵˒³⁶˒⁴³˒⁴⁵ and asthma.⁵˒¹⁵˒¹⁸˒²⁰˒²¹˒²⁸˒³⁰˒³¹˒³³˒³⁹˒⁴²˒⁴⁶˒⁴⁷
    Sulfur: goiter,⁸˒⁹˒²⁴˒³⁰ lymphatic disorders,⁵˒⁸˒⁹˒¹¹˒²¹˒³⁰˒³¹˒³⁶˒⁴³˒⁴⁸ scleroderma,⁸˒⁹˒⁴³ and asthma.⁵˒⁹˒¹⁰˒¹⁸˒²²˒²³˒³⁰˒³¹˒³⁴˒³⁶˒³⁸˒⁴²˒⁴⁷˒⁴⁹
    Natrium diethyl­oxalaceticum: asthma, cancerous conditions,¹ myopathia, and energy-deficit syndrome.³
    Acidum fumaricum: asthma, cancer, rheumatism,¹ and allergies of any kind.
    Acidum DL-malicum: asthma, precancerous conditions and neoplasma,¹ and rheumatic disorders.³
    Acidum alpha-ketoglutaricum: muscle and connective tissue disorders, soft tissue rheumatism,³ asthma, and precancerous conditions and neoplasma.¹
    Adenosinum triphosphoricum: cellular energy deficit¹˒³ and chronic fatigue syndrome.³

    Clinical notes
    Because of the individual constituents of Thyreoidea compositum, the medication can be offered for the following conditions:

    1. Adjunctive treatment in the dedifferentiation phases: precancerous conditions and frank neoplasms of various origins.
    2. Degenerative conditions: muscular dystrophy and arthrosis.
    3. Connective tissue dysfunction and disease: myxedema and scleroderma.
    4. Lymphatic disorders.
    5. Respiratory conditions: bronchial asthma.
    6. Gouty diathesis.

    Note:
    The unique formulation of Thyreoidea compositum makes it a medication with a broad application. It is especially useful for diseases classified on the right of the regulation/compensation division.

    References

    1. Reckeweg H-H. Homoeopathia Antihomotoxica: Symptomen-und Modalitätenverzeichnis mit Arzneimitteltherapie. Vol 1-2. 6th ed. Baden-Baden, Germany: Aurelia Verlag; 1999.
    2. Reinhart E. Suis-Organpräparate in der Homotoxikologie. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1994.
    3. Schmid F, Hamalick P. Antihomotoxische Medizin–Band II: Homöopathische Antihomotoxika. Vol 2. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1996.
    4. Boericke W. Pocket Manual of Homoeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 9th ed. Santa Rosa, CA: Boericke & Tafel; 1927.
    5. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1-3. 3rd ed. Bradford, England: Health Science Press; 1977.
    6. Hale EM. Special Symptomatology of the New Remedies. New Delhi, India: Jain Publishers Ltd; 1993.
    7. Lilienthal S. Homoeopathic Therapeutics. 5th ed. Calcutta, India: Sett Dey & Co.; 1925.
    8. Murphy R. Homeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagosa Springs, CO: Hahnemann Academy of North America; 1993.
    9. Schroyens F. Synthesis: Repertorium Homeopathicum Syntheticum. 9th ed. London, England: Homeopathic Book Publishers; 2004.
    10. Vermeulen F. Concise Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
    11. Murphy R. The Homeopathic Remedy Guide: 1200 Homeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
    12. Blackwood AL. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homoeopathic Links; 1922.
    13. Allen KC. Keynotes and Characteristics With Comparisons of Some of the Leading Remedies of the Materia Medica. 12st ed. Wellingborough, England: Thorsons Publishers Ltd; 1988.
    14. Douglas MAS. Pearls of Homeopathy. 1st ed. New Delhi, India: Jain Publishers Ltd; 1903.
    15. Mohanty N. Text-Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
    16. Vermeulen F. Synoptic Materia Medica Vol. 1. 6th ed. Haarlem, the Netherlands: Merlijn Publishers; 2000.
    17. Vermeulen F. Prisma–The Arcana of Materia Medica Illuminated–Similars and Parallels Between Substance and Remedy. 2nd ed. Haarlem, the Netherlands: Emryss Publishers; 2002.
    18. Allen TF. Handbook of Materia Medica and Homeopathic Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1889.
    19. Allen TF. A Primer of Materia Medica for Practitioners of Homeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
    20. Buck W. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
    21. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
    22. Cleveland CL. Standard Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1982.
    23. Dewey WA. Physical Examination and Observations in Homoeopathy. 1st ed. Gent, Belgium: Homoeodon Boekservice; 1992.
    24. Dewey WA. Practical Homeopathic Therapeutics. 3rd ed. Philadelphia, PA: Boericke & Tafel; 1934.
    25. Dunham C. Homeopathy: The Science of Therapeutics (A Collection of Papers Elucidating and Illustrating the Principles of Homeopathy). 1st ed. Philadelphia, PA: Boericke & Tafel; 1871.
    26. Gupta DR. Dictionary of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1-2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    27. Hahnemann S. The Chronic Diseases, Their Peculiar Nature and Their Homeopathic Cure. Tafel LH, trans-ed. Vol 1-2. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1981.
    28. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1-12. 1st ed. Ridgewood, NY: Gregg Press Inc.; 1964.
    29. Dunham C. Lectures on Materia Medica. 3rd ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1934.
    30. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1-10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
    31. Materia Medica–Synoptics. Vol 1-2. New Delhi, India: Jain Publishers Ltd; 1979.
    32. Kent JT. Lectures on Homoeopathic Materia Medica. 4th ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1946.
    33. Kulkarni S. Gynaecologic and Obstetric Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1994.
    34. Royal G. Textbook of Homoeopathic Materia Medica. 1st ed. Calcutta, India: Roy Publishing House; 1920.
    35. Burt WH. Physiological Materia Medica. 5th ed. Chicago, IL: Gross & Delbridge; 1896.
    36. Gibson DM. Studies of Homeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
    37. Roberts HA. The Studies of Remedies by Comparison. 1st ed. New Delhi, India: Jain Publishers Ltd; 1979.
    38. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1929.
    39. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1990.
    40. Phatak SR. Materia Medica of Homoeopathic Medicines. 1st ed. London, England: Kolve-Vaughan Publishers; 1980.
    41. Julian OA. Materia Medica of New Homoeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1990.
    42. Boericke GA. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
    43. Farrington H. Homoeopathy and Homoeopathic Philosophy (Prepared for and Offered Only to Graduate Physicians). 1st ed. Philadelphia, PA: American Homeopathic Pub Co.; 1922.
    44. Farrington EA. Comparative Materia Medica. 3rd ed. New Delhi, India: Jain Publishers Ltd; 1983.
    45. Hughes R. Manual of Homoeopathic Pharmacodynamics. 5th ed. London, England: Leath & Ross; 1886.
    46. Hahnemann S. Materia Medica Pura. Vol 1-2. 1st ed. London, England: Homeopathic Book Publishers; 1880.
    47. Herscu P. The Homeopathic Treatment of Children: Pediatric Constitutional Types. 1st ed. Berkeley, CA: North Atlantic Books; 1991.
    48. Hughes R, Dake JP. A Cyclopaedia of Drug Pathogenesy. Vol 1-4. 1st ed. New Delhi, India: World Homoeopathic Links; 1891.
    49. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Salzer & Co; 1935.